Very well done and detailed response on RECELL GO issue. I also thought that JC addressed the issue very extensively. The February revenue update should be very interesting. This is the type of innovation that will feed upon it itself with repeat business and market share gains. The company needs to expand research coverage in the U.S., The share volume here is very anemic and given such an exciting innovation, I could see that changing rapidly under the right circumstances.
New Avita Medical Seeking Alpha Analysis by WST, page-31
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.97 |
Change
-0.080(2.62%) |
Mkt cap ! $202.2M | |||
| Open | High | Low | Value | Volume |
| $3.03 | $3.03 | $2.96 | $304.6K | 102.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $2.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.00 | 124952 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |